Sources Contact Advanced Search Tutorials

An Interest In:

Web News this Week

Search Archive

Some of Our Sources

View All Sources

Help Webnuz

Referal links:

March 23, 2021 04:51 pm

India Battles a Second Covid-19 Wave and Vaccine Skepticism

An anonymous reader shares a report: India is racing to contain a second wave of the coronavirus, but its vaccination campaign is running into doubters like Akbar Mohamed Patel. A resident of Mumbai's densely populated slum area of Dharavi, Mr. Patel survived a severe bout of the coronavirus in May. The first wave prompted Mumbai officials to seal off his housing complex, confining thousands of people for nearly two months. Still, the current campaign has been marred by a slow initial government rollout, as well as skepticism and apathy from people like Mr. Patel and his neighbors. "On social media we come to know this is all a big game to make money," Mr. Patel said. Of the vaccine, he said, "many things have been hidden." The coronavirus, once seemingly in retreat, is again rippling across India. Confirmed infections have risen to about 31,600 daily from a low of about 9,800 in February. In a recent two-week period, deaths shot up 82 percent. The outbreak is centered on the state of Maharashtra, home to Mumbai, the country's financial hub. Entire districts of the state have gone back into lockdown. Scientists are investigating whether a new strain found there is more virulent, like variants found in Britain, South Africa and Brazil. Officials are under pressure from Prime Minister Narendra Modi to aggressively ramp up testing and vaccination, especially in Mumbai, to avoid disruptions like last year's dramatic nationwide lockdown and resulting economic recession. "I am very categorical that we should stop it, contain it, just here," said Dr. Rahul Pandit, a critical care physician at a private hospital in Mumbai and a member of the Maharashtra Covid-19 task force. India's vaccination campaign could have global consequences. Last week, Prime Minister Boris Johnson said that an expected drop in Britain's Covid-19 vaccine supplies stemmed from a nearly monthlong delay in delivery of five million doses of the Oxford-AstraZeneca vaccine being manufactured in India. The reasons for the delay are not clear, but the manufacturer, Serum Institute of India, has said shipments will depend in part on domestic Indian needs.

Slashdot

Slashdot was originally created in September of 1997 by Rob "CmdrTaco" Malda. Today it is owned by Geeknet, Inc..

More About this Source Visit Slashdot